Bayer Shares Lose $11.2b in Value but Herbicide Firms Defend Roundup After Court’s Cancer Ruling
21 March 2019 Bayer shares have plummeted in Europe overnight while major herbicide companies have defended weed killer glyphosate following a successful U.S. court action against the product, saying it had been used for decades and that many studies had confirmed the product was safe, reports Darren Gray of The Sydney Morning Herald.
“We continue to believe firmly that the science confirms that glyphosate-based herbicides do not cause cancer,” Bayer said in a lengthy statement in response to a trial underway in the U.S. District Court in San Francisco, California.
On Tuesday, a U.S. jury found in a unanimous ruling that the glyphosate-based weed killer Roundup was a “substantial factor” in causing the cancer of California resident Edwin Hardeman.
